Latest Capital Raising News

Page 83 of 642
PYC Therapeutics has gained Orphan Drug Designation from the European Medicines Agency for its VP-001 candidate targeting Retinitis Pigmentosa type 11, enhancing its regulatory and commercial pathway in Europe.
Ada Torres
Ada Torres
27 Apr 2026
Babylon Pump & Power’s shares remain suspended from ASX trading as the company delays disclosure of a material transaction and capital raising, prolonging market uncertainty beyond the initial deadline.
Victor Sage
Victor Sage
27 Apr 2026
Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.
Victor Sage
Victor Sage
27 Apr 2026
SenSen Networks reported a 17% increase in annual recurring revenue to $11 million and positive operating cash flow of $0.9 million in Q3 FY26 despite supply chain disruptions delaying some projects. The company’s full-year EBITDA is expected to improve significantly over FY25.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Corella Resources has agreed to acquire a majority interest in the Chobe Project, expanding its footprint in Western Australia’s emerging rare earths and niobium hotspot. The acquisition is backed by a heavily oversubscribed $5 million capital raise.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Corella Resources has agreed to acquire a majority interest in the Chobe Project, a highly prospective niobium and rare earths ground in Western Australia’s West Arunta, supported by a heavily oversubscribed $5 million capital raise.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Beetaloo Energy has launched a $5 million Share Purchase Plan at $0.28 per share, following a $66.3 million institutional placement at the same price. The SPP aims to fund ongoing development activities ahead of first gas production in late 2026.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Altair Minerals has landed a A$28.2 million strategic placement from Endeavour Mining’s subsidiary at a premium, boosting its treasury to about A$40 million and enabling a major expansion of exploration at the Greater Oko gold project in Guyana.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Solstice Minerals has pushed the boundaries of its Nanadie Copper-Gold Project in WA, completing the deepest drillhole to date and logging visible copper sulphides well below previous resource levels. Assay results are pending, but early signs point to meaningful extensions of the mineralised system.
Maxwell Dee
Maxwell Dee
27 Apr 2026
X2M Connect accelerated revenue growth in Q3 FY26 with a 67% increase, driven by strong demand in South Korea and new Australian smart community deals. The company’s capital raise and expanding customer base underpin its push into new markets despite ongoing cash burn.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.
Ada Torres
Ada Torres
27 Apr 2026
Harvest Technology Group sharpened its international defence focus in Q1 2026, onboarding NATO and commercial clients to its Nodestream platform, progressing new video features, and appointing Jeff Sengelman as Executive Chair amid CEO transition.
Sophie Babbage
Sophie Babbage
27 Apr 2026